Liver and Intrahepatic Bile Duct Carcinoma
NCI Definition: A carcinoma that arises from the hepatocytes or intrahepatic bile ducts. The main subtypes are hepatocellular carcinoma (hepatoma) and cholangiocarcinoma. 
There are 2 clinical trials for liver and intrahepatic bile duct carcinoma, of which 1 is open and 1 is completed or closed. Of the trials that contain liver and intrahepatic bile duct carcinoma as an inclusion criterion, 2 are phase 1 (1 open).
Cdx-1140 and recombinant flt3 ligand are the most common interventions in liver and intrahepatic bile duct carcinoma clinical trials.
2. The AACR Project GENIE Consortium. AACR Project GENIE: powering precision medicine through an international consortium. Cancer Discovery. 2017;7(8):818-831. Dataset Version 6. This dataset does not represent the totality of the genetic landscape; see paper for more information.